Lipoprotein(a) in plasma, arterial wall, and thrombus from patients with aortic aneurysm

Clinical Genetics

Volumn 52, Issue 5, 1997, Pages 262-271

  Papagrigorakis, Emmanouel ^a   Iliopoulos, Dimitrios ^a   Asimacopoulos, P J ^a   Safi, Hazim J ^a   Weilbaecher, Donald J ^a   Ghazzaly, Karima G ^a   Nava, Mauro L ^a   Gaubatz, John W ^a   Morrisett, Joel D ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Aneurysm; Aorta; Atherosclerosis; Elastin; Glycosaminoglycans; Lipoprotein(a); Thrombus; Tissue repair; Wound heeling

Indexed keywords

GLYCOSAMINOGLYCAN; LIPOPROTEIN A;

ADULT; AGED; ANGIOGENESIS; AORTA ANEURYSM; AORTA ATHEROSCLEROSIS; ARTERY WALL; CLINICAL ARTICLE; CONFERENCE PAPER; ELASTIC FIBER; FEMALE; HUMAN; HUMAN TISSUE; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; THROMBUS;

ELAGATIS; THROMBUS;

EID: 0031427440     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.1997.tb04343.x     Document Type: Conference Paper

References (59)

1. Angles-Cano E, Hervio L, Rouy D, Fournier C, Chapman JM, Laplaud M, Koschinsky ML. Effects of lipoprotein(a) on the binding of plasminogen to fibrin and its activation by fibrin-bound tissue-type plasminogen activator. Chem Phys Lipids 1994 : 67/68: 369-380.
2. Bihari-Varga M, Gruber E, Rotheneder M, Zechner R, Kostner G. Interaction of lipoprotein(a) and low density lipoprotein with glycosaminoglycans from human aorta. Arteriosclerosis 1987: 8: 851-857.
3. Bostom AG, Cupples LA, Jenner JL, Ordovas JM, Seman LJ, Wilson PWF, Schaefer EJ, Castelli MD. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. J Am Med Assoc 1996: 276: 544-548.
4. Brown SA, Morrisett JD, Boerwinkle E, Hutchinson R, Patsch W. The relation of lipoprotein(a) concentrations and apoprotein(a) phenotypes with asymptomatic arteriosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb 1993: 13: 1558-1566.
5. Buggy D, Breathnach A, Keogh B, Cooke T, Feely J. Lipoprotein(a) and treatment of chronic renal disease. J Intern Med 1993: 234: 453-455.
6. Cantin B, Moorjani S, Dagenais GR, Lupien PJ. Lipoprotein(a) distribution in a French Canadian population and its relation to intermittent claudication (The Quebec Cardiovascular Study). Am J Cardiol 1995: 75: 1224-1228.
7. Cardoso GC, Posadas C, Orvananos OO, Peniche C, Zamora J, Aguilar R, Holguin JA, Raynaud AS, Morrisett JD, Guevara J. Long-distance runners and body-builders exhibit elevated plasma levels of lipoprotein(a). Chem Phys Lipids 1994: 67/68: 207-221.
8. Cohen JR, Sarfati I, Danna D, Wise L. Smooth muscle cell elastase, atherosclerosis, and abdominal aortic aneurysms. Anal Surg 1992: 9: 327-330.
9. Craig WY, Kloza EM, Haddow JE, Hitchcock JL. Lipoprotein(a) levels in peripheral atherosclerotic disease. Letters to the Editors. J Vasc Surg 1995: 21: 541-542.
10. Cushing GL, Gaubatz JW, Nava ML, Burdick BJ, Bocan TMA, Guyton JR, Weilbaecher D, DeBakey ME, Lawrie GM, Morrisett JD. Quantitation and localization of apolipoproteins (a) and B in coronary artery bypass vein grafts resected at reoperation. Arteriosclerosis 1989: 9: 593-603.
11. Dahlen G, Berg K, Gillnas T, Ericson C. Lp(a) lipoprotein prebetal-lipoprotein in Swedish middle-aged males and in patients with coronary heart disease. Clin Genet 1975: 7: 334-341.
12. Desoye G, Schweditsch MO, Pfeiffer KP, Zechner R, Kostner GM. Correlation of hormones with lipid and lipoprotein levels during normal pregnancy and postpartum. J Clin Endocrin Metab 1987: 64: 704-712.
13. Dieplinger H, Lackner C, Kronenberg F, Sandholzer C, Lhotta K, Hoppichler F, Graf H, Konig P. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a). J Clin Invest 1993: 91: 397-401.
14. Edelberg J, Pizzo SV. Lipoprotein (a) regulates plasmin generation and imbibition. Chem Phys Lipids 1994: 67/68: 363-368.
15. Ericson C, Dahlen G, Berg K. Interaction of isolated Lp(a) lipoprotein with calcium ions and glycosaminoglycans in vitro. Clin Genet 1977: 11: 433-440.
16. Farrer M, Game FL, Albers CJ, Andrews H, Neil W, Winocour PH, Laker MF, Adams PC, George K, Alberti MM. Coronary artery disease is associated with increased lipoprotein(a) concentrations independent of the size of circulating apolipoprotein(a) isoforms. Arterioscler Thromb 1994: 14: 1272-1283.
17. Fowkes FGR, Greenhalgh RM, Mannick JA, Powell JT. In: Greenhaigh RM, Mannick JA, eds. The cause and management of aneurysms. London: WB Saunders, 1990: 19-28.
18. Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 1995: 15: 1145-1151.
19. Friedewald WT, Levy RI, Fredrickson D. Estimation of the concentration of low-density lipoprotein in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972: 18: 499-502.
20. Gaubatz JW, Cushing GL, Morrisett JD. Quantitation, isolation and characterization of human lipoprotein(a). Methods Enzymol 1986: 129: 176-185.
21. Gaubatz JW, Ghanem KI, Guevara J, Nava ML, Patsch W, Morrisett JD. Polymorphic forms of human apolipoprotein(a): inheritance and relationship of their molecular weights to plasma levels of lipoprotein(a). J Lipid Res 1990: 31: 603-613.
22. Grainger DJ, Kemp PR, Liu AC, Lawn RM, Metcalfe JC. Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice. Nature 1994: 370: 460-462.
23. Grainger DJ, Kirschenlohr HL, Metcalf JC, Weissberg PL, Wade DP, Lawn RM. Proliferation of human smooth muscle cells promoted by lipoprotein(a). Science 1993: 260: 1655-1658.
24. Hajjar KA, Nachman RL. The role of lipoprotein(a) in atherogenesis and thrombus. Annu Rev Med 1996: 47: 423-442.
25. Hearn JA, Donohue BC, Baalbaki H, Douglas JS, King SB, Lembo NJ, Ronbin GS, Sgoutas DS. Usefulness of serum lipoprotein[a] as a predictor of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1992: 69: 736-739.
26. Hoefler G, Harnoncourt F, Paschke E, Mirtl W, Pfeiffer KH, Kostner GM. Lipoprotein Lp(a): a risk factor for myocardial infarction. Arterioscler 1988: 8: 398-401.
27. Hoff HF, Beck GJ, Skibinski CI, Jurgens G, O'Neil JA, Kramer J, Lytle B. Serum Lp(a) level as predictor of vein graft stenosis after coronary artery bypass surgery in patients. Circulation 1988: 77: 1238-1244.
28. Hoff HF, O'Neil J, Smejkal GB, Yashiro A. Immunochemically detectable lipid-free apo(a) in plasma and in human atherosclerotic lesions. Chem Phys Lipids 1994: 67/68: 271-280.
29. Jamieson DG, Usher DC, Rader DJ, Lavi E. Apolipoprotein(a) deposition in atherosclerotic plaques of cerebral vessels. A potential role for endothelial cells in lesion formation. Am J Pathol 1995: 147: 1567-1574.
30. Jaques LW, Riesco BF, Weltner W, Jr. N.M.R. spectroscopy and calcium binding of sialic acids: N-glycolylneuraminic acid and periodate-oxidazed N-acetylneuraminic acid. Carbohydrate Res 1980: 83: 21-32.
31. Jurgens G, Koltringer P. Cerebrovascular disease and Lp(a): its role in atherosclerotic plaque formation and vessel wall elasticity of the carotid arteries. Chem Phys Lipids 1994: 67/68: 429-434.
32. Kokoglu E, Karaarslan I, Karaarslan HM, Baloglu H. Elevated serum Lp(a) levels in the early and advanced stages of breast cancer. Cancer Biochem Biophys 1994: 14: 133-136.
33. Koschinsky ML, Beisiegel U, Henne-Bruns D, Eaton DL, Lawn RM. Apolipoprotein(a) size heterogeneity is related to variable number of repeat sequences in its mRNA. Biochemistry 1990: 29: 640-644.
34. Kostner GM, Avogaro P, Cazzolato G, Marth E, Bittolo-Bon G, Qunici GB. Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis 1981: 38: 51-61.
35. Kronenberg F, Kathrein H, Konig P, Neyer U, Sturm W, Lhotta K, Grochenig E, Utermann G, Dieplinger H. Apolipoprotein(a) phenotypes predict the risk for carotid atherosclerosis in patients with end-stage renal disease. Arterioscler Thromb 1994: 14/9: 1405-1411.
36. Lackner C, Boerwinkle E, Laffert CC, Rahmig T, Hobbs HH. Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. J Clin Invest 1991: 87: 2153-2161.
37. Lawn RM, Wade DP, Hammer RE, Chiesa G, Verstuyft JG, Rubin EM. Atherogenesis in transgenic mice expressing human apolipoprotein(a). Nature 1992: 360: 670-672.
38. Li KM DE, Wilcken L, Dudman NPB. Effect of serum lipoprotein(a) on estimation of low-density lipoprotein cholesterol by the Friedewald Formula. Clin Chem 1994: 40: 71-73.
39. Liu J-N, Harpel PC, Gurewich V. Fibrin-bound lipoprotein(a) promotes plasminogen binding but inhibits fibrin degradation by plasmin. Biochemistry 1994: 33: 2554-2560.
40. Maeda S, Abe A, Seishima M, Makino K, Noma A, Kawade M. Transient changes of serum lipoprotein(a) as an acute phase protein. Atherosclerosis 1989: 78: 145-150.
41. McLean JW, Tomlinson JE, Kuang W-J, Eaton DL, Chen EY, Fless GM, Scanu AM, Lawn RM. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987: 330: 132-137.
42. Nagele U, Hagele E, Sauer G, Wiedermann E, Lehmann P, Wahlefeld AW, Gruber W. Reagent for the enzymatic determination of serum total triglyceride with improved lipolytic efficiency. J Clin Chem Cli Biochem 1984: 22: 165-174.
43. Nielsen LB, Stender S, Kjeldsen K, Nordestgaard BG. Specific accumulation of lipoprotein(a) in balloon-injured rabbit aorta in vivo. Circ Res 1995: 78: 615-626.
44. Niendorf A, Stang A, Beisiegel U, Peters A, Nagele H, Gebhardt A, Kuse R. Elevated lipoprotein(a) levels in patients with acute myeloblastic leukaemia decrease after successful chemotherapeutic treatment. Clin Invest 1992: 70: 683-685.
45. Norrgard D, Angguist KA, Dahlen G. High concentrations of Lp(a) lipoprotein in serum are common among patients with abdominal aortic aneurysms. Int Angiol 1988: 7: 46-49.
46. Pepin JM, O'Neil JA, Hoff HF. Quantification of apo(a) and apoB in human atherosclerotic lesions. J Lipid Res 1991: 32: 317-327.
47. Peterson GL. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 1977: 83: 346-356.
48. Podet EJ, Shaffer DR, Gianturco SH, Bradley WA, Yang C-Y, Guyton JR. Interaction of low density lipoproteins with human aortic elastin. Arterioscler Thromb 1990: 11: 116-122.
49. Rhoads GG, Dahlen GH, Berg K, Morton NE, Dannenberg AL. Lp(a) lipoprotein as a risk factor for myocardial infarction. J Am Med Assoc 1986: 256: 2540-2544.
50. Safi HJ, Bartoli S, Hess KR, Shenaq SS, Victs JR, Butt GR, Sheinbaum R, Doerr HK, Maulsby R, Rivers VM. Neurologic deficit in patients at high risk with thoracoabdominal aortic aneurysms: the role of cerebral spinal fluid drainage and distal aortic perfusion. J Vasc Surg 1994: 20: 434-443.
51. Sandholzer C, Boerwinkle E, Saha N, Tong MC, Utermann G. Apolipoprotein(a) phenotypes, Lp(a) concentrations and plasma levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease. J Clin Invest 1992: 89: 1040-1046.
52. Sandkamp M, Funke H, Schulte H, Kohler E, Assmann G. Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age. Clin Chem 1990: 6: 20-23.
53. Schaefer EJ, Lamon-Fava L, Jenner JL, McNamara JR, Ordovas JM, Davis EC, Abolafia JM, Lippel K, Levy RI. Lipoprotein(a) levels and risk of coronary heart disease in men. J Am Med Assoc 1994: 271: 999-1003.
54. Siedel J, Hagele E, Ziegenhorn J, Wahlenfeld AW. Reagent for the enzymatic of serum total cholesterol with improved lipolytic efficiency. Clin Chem 1983: 29: 1075-1080.
55. Sutton-Tyrrell K, Evans RW, Meilahn E, Alcorn HG. Lipoprotein(a) and peripheral atherosclerosis in older adults. Atherosclerosis 1995: 122: 11-19.
56. Valentine RJ, Grayburn PA, Vega GL, Grundy SM. Lp(a) lipoprotein is an independent, discriminating risk factor for premature peripheral atherosclerosis among white men. Arch Intern Med 1994: 154: 801-806.
57. 2+ precipitation procedure for quantification of high-density-lipoprotein cholesterol. Clin Chem 1982: 28: 1379-1388.
58. Willeit J, Kiechl S, Santer P, Oberhollenzer F, Egger G, Jarosch E, Mair A. Lipoprotein(a) and asymptomatic carotid artery disease. Evidence of a prominent role in the evolution of advanced carotid plaques: The Bruneck Study. Stroke 1995: 26: 1582-1587.
59. Wright LC, Sullivan DR, Muller M, Dyne M, Tattersall MHN, Mountford CE. Elevated apolipoprotein(a) levels in cancer patients. Int J Cancer 1989: 43: 241-244.